Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Galimberti

Showing results (31-40 of 313) with videos related to

Pageof 32
Sort By:
Journal of Chemotherapy (Florence, Italy)|July 26, 2016
How to treat splenic marginal zone lymphoma (SMZL) in patients unfit for surgery or more aggressive therapies: experience in 30 casesGiulia Cervetti, Francesco Ghio, Nadia Cecconi, et al.
Leukemia Research|January 15, 2008
Bortezomib is able to reduce angiogenesis in half of patients affected by idiopathic myelofibrosis: an ex vivo studySara Galimberti, Martina Canestaro, Eugenio Ciancia, et al.
Hematological Oncology|April 3, 2008
Acute myeloid leukaemia after treatment with (90)Y-ibritumomab tiuxetan for follicular lymphomaDaniele Focosi, Nadia Cecconi, Giuseppe Boni, et al.
Leukemia Research|April 25, 2008
JAK-2V617F mutation in RARS-t: a target for Imatinib therapy?Elisa Cannizzo, Giovanni Carulli, Antonio Azzarà, et al.
Blood Cells, Molecules & Diseases|August 1, 2015
Increased values of the circulating PDGFβ sustains the "withdrawal syndrome" after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemiaSara Galimberti, Giulia Fontanelli, Sara Barsotti, et al.
European Heart Journal|August 3, 2021
The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasmsChiara Baldini, Francesca Romana Moriconi, Sara Galimberti, et al.
Annals of Hematology|June 11, 2013
Imaging studies in extramedullary hematopoiesis of the spleenBenedetta Matteuzzi, Lisa Pieri, Francesca Lisi, et al.
Annals of Hematology|January 11, 2007
Folate levels in cancer: a vitamin for a new challengeGabriele Buda, Valentina Maggini, Sara Galimberti, et al.
European Journal of Haematology|March 19, 2026
The Role of Microenvironment in Bispecific Antibodies Treatment in Multiple MyelomaSerena Barachini, Raffaella Cassano Cassano, Francesca Ronca, et al.
Cancer Research|December 26, 2003
Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blastsAntonella Gozzini, Elisabetta Rovida, Persio Dello Sbarba, et al.
Pageof 32

Showing results (31-40 of 313) with videos related to

Sort By:
Pageof 32
Journal of Chemotherapy (Florence, Italy)|July 26, 2016
How to treat splenic marginal zone lymphoma (SMZL) in patients unfit for surgery or more aggressive therapies: experience in 30 casesGiulia Cervetti, Francesco Ghio, Nadia Cecconi, et al.
Leukemia Research|January 15, 2008
Bortezomib is able to reduce angiogenesis in half of patients affected by idiopathic myelofibrosis: an ex vivo studySara Galimberti, Martina Canestaro, Eugenio Ciancia, et al.
Hematological Oncology|April 3, 2008
Acute myeloid leukaemia after treatment with (90)Y-ibritumomab tiuxetan for follicular lymphomaDaniele Focosi, Nadia Cecconi, Giuseppe Boni, et al.
Leukemia Research|April 25, 2008
JAK-2V617F mutation in RARS-t: a target for Imatinib therapy?Elisa Cannizzo, Giovanni Carulli, Antonio Azzarà, et al.
Blood Cells, Molecules & Diseases|August 1, 2015
Increased values of the circulating PDGFβ sustains the "withdrawal syndrome" after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemiaSara Galimberti, Giulia Fontanelli, Sara Barsotti, et al.
European Heart Journal|August 3, 2021
The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasmsChiara Baldini, Francesca Romana Moriconi, Sara Galimberti, et al.
Annals of Hematology|June 11, 2013
Imaging studies in extramedullary hematopoiesis of the spleenBenedetta Matteuzzi, Lisa Pieri, Francesca Lisi, et al.
Annals of Hematology|January 11, 2007
Folate levels in cancer: a vitamin for a new challengeGabriele Buda, Valentina Maggini, Sara Galimberti, et al.
European Journal of Haematology|March 19, 2026
The Role of Microenvironment in Bispecific Antibodies Treatment in Multiple MyelomaSerena Barachini, Raffaella Cassano Cassano, Francesca Ronca, et al.
Cancer Research|December 26, 2003
Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blastsAntonella Gozzini, Elisabetta Rovida, Persio Dello Sbarba, et al.
Pageof 32